PetMed Express Issues Q2 and 6 Months Earnings Guidance for FY25

PetMed Express has provided earnings guidance for its fiscal second quarter and six months ended September 30, 2025. The company expects net sales for the quarter to be between $43.4 million and $44.5 million, compared to $58.0 million in the prior year period. For the six months, net sales are expected to be between $94.5 million and $95.6 million, compared to $124.3 million in the prior year period.